Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model

, , Comments Off on Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model

says Brad Loncar of Loncar Investments Viva Biotech is the fourth largest company in China’s drug discovery services industry, with a 2.6 per cent market share. Photo: Bloomberg Viva Biotech’s hugely …
( read original story …)